Skip to main content
. 2012 May 10;2012:159568. doi: 10.5402/2012/159568

Figure 1.

Figure 1

Kaplan-Meier plot of time to progression (TTP) in 36 patients treated with biweekly gemcitabine and docetaxel. Median TTP was 2.3 months (95% CI: 1.5–3.8 months). The 3-month TTP rate was 45% (95% CI: 27–63%). The 6-month TTP rate was 17% (95% CI: 1–32%).